|
CA2470813A1
(en)
|
2001-12-20 |
2003-07-03 |
Bayer Healthcare Ag |
1,4-dihydro-1,4-diphenylpyridine derivatives
|
|
US7230017B2
(en)
|
2002-08-27 |
2007-06-12 |
Bayer Healthcare Ag |
Dihydropyridinone derivatives
|
|
GB0219896D0
(en)
|
2002-08-27 |
2002-10-02 |
Bayer Ag |
Dihydropyridine derivatives
|
|
GB2392910A
(en)
*
|
2002-09-10 |
2004-03-17 |
Bayer Ag |
2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
|
|
PL375647A1
(en)
|
2002-09-10 |
2005-12-12 |
Bayer Healthcare Ag |
Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
|
|
WO2004024701A1
(en)
|
2002-09-10 |
2004-03-25 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
|
WO2005082863A2
(en)
|
2004-02-26 |
2005-09-09 |
Bayer Healthcare Ag |
1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
|
|
ES2394177T3
(es)
*
|
2004-02-26 |
2013-01-23 |
Bayer Intellectual Property Gmbh |
1,4-diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos
|
|
GB0502258D0
(en)
|
2005-02-03 |
2005-03-09 |
Argenta Discovery Ltd |
Compounds and their use
|
|
GB0512940D0
(en)
|
2005-06-24 |
2005-08-03 |
Argenta Discovery Ltd |
Compounds and their use
|
|
JP4999920B2
(ja)
|
2006-05-04 |
2012-08-15 |
プルマジェン セラピューティクス （インフラメーション） リミテッド |
テトラヒドロピロロピリミジンジオン類およびヒト好中球エラスターゼ阻害薬としてのそれらの使用
|
|
US8198288B2
(en)
|
2006-05-04 |
2012-06-12 |
Pulmagen Therapeutics (Inflammation) Limited |
Tetrahydropyrrolopyrimidinediones and their use in therapy
|
|
WO2009013444A1
(en)
|
2007-07-25 |
2009-01-29 |
Argenta Discovery Limited |
Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
|
|
DE102006031314A1
(de)
|
2006-07-01 |
2008-01-03 |
Bayer Healthcare Aktiengesellschaft |
Verwendung von 1,4-Diaryl-dihydropyrimidin-2-on-Derivaten zur Behandlung der pulmonalen arteriellen Hyptertonie
|
|
US20100010024A1
(en)
|
2006-07-01 |
2010-01-14 |
Bayer Healthcare Ag |
Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
|
|
WO2009037413A1
(en)
|
2007-09-19 |
2009-03-26 |
Argenta Discovery Limited |
Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases
|
|
WO2009060206A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
|
|
WO2009060158A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors
|
|
GB0721866D0
(en)
|
2007-11-07 |
2007-12-19 |
Argenta Discovery Ltd |
Pharmaceutical compounds having dual activities
|
|
MX2010006033A
(es)
|
2007-12-20 |
2010-07-16 |
Bayer Schering Pharma Ag |
4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso.
|
|
DE102007061766A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
4-(4-Cyano-2-thioaryl)-dihydropyrimidinone und ihre Verwendung
|
|
DE102008022521A1
(de)
|
2008-05-07 |
2009-11-12 |
Bayer Schering Pharma Aktiengesellschaft |
1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
|
|
DE102009004197A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
|
|
DE102009016553A1
(de)
|
2009-04-06 |
2010-10-07 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung
|
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
GB201004178D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
JP2013177318A
(ja)
|
2010-06-30 |
2013-09-09 |
Dainippon Sumitomo Pharma Co Ltd |
ジヒドロピリミジノン誘導体およびその医薬用途
|
|
CN104024241B
(zh)
|
2011-08-01 |
2016-01-20 |
大日本住友制药株式会社 |
尿嘧啶衍生物和其用于医学目的的用途
|
|
KR20140060513A
(ko)
|
2011-09-14 |
2014-05-20 |
키에시 파르마슈티시 엣스. 피. 에이. |
인체 호중구 엘라스타제 억제제인 테트라히드로트리아졸로피리미딘 유도체
|
|
US9102624B2
(en)
|
2012-08-23 |
2015-08-11 |
Boehringer Ingelheim International Gmbh |
Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
|
|
US20140057920A1
(en)
|
2012-08-23 |
2014-02-27 |
Boehringer Ingelheim International Gmbh |
Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
|
|
US20140057926A1
(en)
|
2012-08-23 |
2014-02-27 |
Boehringer Ingelheim International Gmbh |
Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
|